The NRG Oncology NRG-GU009 (PREDICT-RT) study evaluating intensified and de-intensified concurrent radiation regimens based on the genomic risk of patients with high-risk prostate cancer completed ...
Genomic profiling can help personalize cancer care, but patients may not be offered these tests due to a burdensome ...
GenomeDx Biosciences today announced that data presented at the 2015 American Society of Clinical Oncology Annual Meeting demonstrate that the Decipher® Prostate Cancer Classifier is a significant ...
An informational website and a mobile testing van in Philadelphia are making it easier to learn about cancer and get tested. Hall of Fame running back Emmitt Smith will be hosting a series of short ...
The European Randomized Study of Screening for Prostate Cancer (ERSPC) was initiated in 1993 to assess the effect of prostate-specific antigen (PSA) testing on prostate cancer mortality. Because ...
Wolinsky is a Chicago-based medical journalist and publisher of The Active Surveillor, a Substack newsletter that covers lower-risk prostate cancer and active surveillance. In 2002, at age 55, I ...
Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment. A recent ...
Long-term results from a European study showed that prostate cancer mortality was 13% lower in the PSA screening group versus the control group. Compared with the trial update at 16 years, the number ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results